Form 4 for SLXN Silexion Therapeutics Corp
Accepted 2025-12-31 00:00:00 ET · period of report 2025-02-09 · accession 0001178913-25-004149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-31 | 2025-02-09 | SLXN | Alon Ruth | Dir | A - Grant | $0.00 | +794 | 794 | New | $0 |
| D | 2025-12-31 | 2025-02-09 | SLXN | Alon Ruth | Dir | A - Grant | $0.00 | +935 | 935 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-02-09 | A | A | 794 | $0.00 | 794 | D | — | — | (F1) Represents ordinary shares underlying RSUs granted to the Reporting Person by the Issuer. The shares subject to this award vest in full on the first anniversary of the date of grant (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date. (F2) The number of ordinary shares reported in this row has been adjusted retroactively to reflect a 1-for-15 reverse share split effected by the Issuer on July 29, 2025. |
| 2 | Derivative | Stock Option (right to buy ordinary shares) | 2025-02-09 | A | A | 935 | $0.00 | 935 | D | $18.90 · 2026-02-09 to 2035-02-09 | 935 Ordinary Shares | (F5) The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025. |